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ABSTRACT 
 
There are confirmed beneficiary effects of exercise on atherosclerotic inflammation of 
ischemia-associated heart diseases. The purpose of this study was to evaluate the effect of 
aerobic exercise on T-regulatory cell markers of IL-35 as well as FoxP3 and T-helper2 
marker of IL-33 in patients with ischemic heart disease (IHD). 
This research was performed on 44 asymptomatic male patients with ischemic heart 
disease. The participants were randomly assigned into two groups of submaximal aerobic 
exercise and control group. Blood samples were collected before and after the termination of 
the exercise protocol. Serum levels of IL-35 and IL-33 as well as the amount of FoxP3 gene 
expression in peripheral blood mononuclear cells were measured by Elisa and Real time 
PCR, respectively. 
Serum levels of IL-35 (p=0.001) as well as the amount of FoxP3 gene expression 
increased significantly (p=0.012)  in exercise group even after controlling the likely 
confounding effects of age, length of ischemia, duration of the disease, and the amount of 
such factors before exercise (p≤0.042). 
It seems that exercise may yield a better control of atherosclerotic inflammation in 
patients with ischemic heart disease through the induction of regulatory T cells. 
 
Keywords: Interleukin-35; Interleukin-33; Regulatory T cells; Sub maximal aerobic 
exercise  
 
INTRODUCTION 
 
Physical inactivity is a well-documented risk factor for  
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optimal bone mineral density;
1
 however, in addition to 
inactivity, there are other pathophysiologic bases of the 
disease associated with inflammation. Over the last 
decades, an abundance of evidence has emerged that 
inflammation plays a role in all phases of the 
atherosclerotic disease process, from lesion initiation to 
progression and, finally, to plaque rupture and the 
consecutive complications of cardiovascular disease.
2,3
 
In fact, the inflammatory reactions are a group of the 
interfering processes in the development of 
arthrosclerosis and its involved complications.
4
 There 
are numerous reports that show physical activity has 
significant beneficiary effects on cardiovascular 
events
5-8 
through reducing the risk factors
9-11
 as well as 
processes of atherosclerosis progression.
12,13
 The 
majority of such studies have examined the changes of 
inflammatory/anti-inflammatory markers such as CRP, 
VCAM-1, ICAM-1, fibrinogen, IL-6, TNF-a, IL-10, or 
TGF-β.14-18  
Regulatory T cells (Tregs), a subset of T cells, 
suppresse different immune cells such as T and B cells, 
natural killer cells, natural killer T cells, mast cells, and 
dendritic cells. The main mechanism of such activity is 
to produce anti-inflammatory cytokines which control 
various types of inflammation through the mediatory 
effect of Fork head box P (Foxp3). Foxp3 is the main 
transcription factor and phenotypic/functional marker 
of Tregs.
19,20
 Results obtained from animal models of 
atherosclerosis have shown the protective and fixing 
role of such cells in atrium plaque.
21
 It seems that lack 
of such protection , which is induced by their anti-
inflammatory cytokines of IL-10 and TGF-β, may lead 
to acute coronary events as well as advanced 
atherosclerosis.
22,23
 IL-35, an IL-12 family cytokine 
secreted by Tregs may have such anti-inflammatory 
effects.
24
 
The response of Tregs to various types of endurance 
exercise has been studied in endurance athletes.
25
 Perry 
et al. reported that there was a decrease in both the 
percentage of Treg lymphocytes and the intensity of 
FoxP3 expression in CD4+CD25+ Tregs following the 
participation in endurance exercise in athletes.
26
 More 
specifically, the response of FoxP3 in ischemic heart 
patients to moderate (submaximal) aerobic endurance 
exercise has not been examined yet. 
IL-33, an IL-1family cytokine secreted by Th2 cells 
and inducing Th2-associated diseases such as asthma, 
may have some protective roles in various 
cardiovascular diseases including atherosclerosis.
26,27
  
It has been demonstrated that mice deprived of IL-33 
receptor, namely IL-33Ra, are afflicted to myocardium 
inflammation, ventricle dilation and cardiac fibrosis. In 
addition, the increase in extracellular IL-33Ra level is a 
predictor of clinical myocardial infarction.
28
 
This research was designed, for the first time, to 
examine the effect of submaximal aerobic instead of 
intensive aerobic exercise on regulatory T-cells, 
focusing on two secretory-relevant markers of IL-35 
and IL-33 as well as the cell-relevant markers of 
FoxP3 gene expression in male patients with ischemic 
heart diseases. Such knowledge may help us to 
prevent the cardiovascular disorders or to accelerate 
patients' recovery by promoting anti-inflammatory 
mechanisms. 
 
MATERIALS AND METHODS 
 
Patients 
This semi-experimental research included 44 
volunteered asymptomatic male patients with ischemic 
heart disease diagnosed in Shahid Beheshti Hospital of 
Kashan University of Medical Sciences. All the 
patients underwent angiography and at least one of the 
arteries had 75%or more stenosis. They were randomly 
assigned into two groups of 21 who participated in 
prescribed submaximal aerobic exercise and 23 patients 
served as the control group participating in routine 
regular physical activities. Men were chosen 
considering the fact that they are more likely to suffer 
from such ischemic heart diseases at younger age than 
women; moreover, men at this age are more likely to  
be able to participate and complete an exercise 
program. Both groups received their identical regular 
treatment. Blood samples were collected before and 
after the termination of the exercise protocol. The 
exclusion criteria were any clinical or ECG changes 
during the exercise, any cardiovascular event within  
the last 3 months, being candidate for revascularization, 
ventricular tachycardia, uncontrolled hypertension, 
malignancy, diabetes, autoimmune diseases, allergy, 
chronic or acute infectious diseases, kidney or liver 
failure, use of immune-modulating drugs and 
erythropoietin, peripheral vascular diseases limiting 
physical activities, valvular heart diseases, and 
obstructive pulmonary disease. Both control  
and exercise groups received their identical 
conventional medication. The ethical committee of the 
Kashan University of Medical Sciences approved the 
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project and informed consent was signed by the 
participants. 
 
Exercise Protocol 
The submaximal aerobic exercise was determined 
based on formula described in most exercise related 
texts
29
 and included three sessions of exercise 
continued for 12 weeks. An exercise science 
specialist designed and supervised the exercise 
protocol. The participants in exercise group 
performed 5 minutes of mild warm-up exercise prior 
to performing 40 minutes of submaximal aerobic 
exercise followed by 5 minutes of cool-down 
stretching exercises. The target heart rate was 
monitored by Pollar watch model M300set (China). 
The health condition of every participant was 
assessed at the beginning of every exercise session. 
Weekly general health condition of the participants 
was evaluated by a cardiologist. 
 
Elisa and Real-time Experiments 
24 before and after the termination of the 
exercise program, 5 cc of venous blood sample was 
collected from the left arm of the all participants and 
kept frozen in EDTA-containing tubes until the 
assays. Serum levels of IL-33 and IL-35 were 
measured by ELISA sandwich method (eBioscience 
kit, USA) According to manufacturer's instructions. 
Total RNA was extracted from peripheral blood 
mononuclear cells (PBMC) using High Pure RNA 
Isolation Kit (Cat No: 11828665001, Roche Applied 
Science, Germany). cDNA synthesized from the 
extracted RNA using Transcriptor First Strand 
cDNA Synthesis Kit (Cat No: 04897030001, Roche 
Applied Science , Germany). The amount of FoxP3 
gene expression was measured using Taqman primer 
probe Comparative CT method) ABI 7300 Real-
Time PCR system, USA(. β-actin housekeeping gene 
was used as endogenous control. FoxP3 gene 
expression in exercise group relative to control 
group was determined as 2
∆∆-CT
.  
 
Statistical Analysis 
Data were analyzed using descriptive statistics 
including mean and standard deviations. The 
measurements were compared before and after the 
exercise using paired and in both groups by 
independent T-tests. Analysis of covariance 
(ANCOVA) was employed to control the 
confounding variables and baseline differences. The 
entire significant test was performed by alpha level 
set to 0.05. SPSS 16.0 (Chicago, USA) and STATA 
software 11, (Stata Corp., College Station, TX, 
USA), were used to analyze the data. 
 
RESULTS 
 
Basic and clinical characteristics of the patients 
have been included in Table 1.  
There was no significant difference between the 
two groups regarding to serum levels of IL-35 and 
IL-33 as well as the amount of FoxP3 gene 
expression before exercise. 
The changes of both IL-35 serum levels and 
FoxP3 gene expression in exercise group were 
significantly higher after the exercise in comparison 
with those of before exercise (p≤0.012) (Table 2). 
The amount of FoxP3 gene expression increased 
significantly in exercise group compared to control 
group in post-test condition (p=0.012) (Table 2). 
There were differences in IL-35 and IL-33 serum 
levels as well as the amount of FoxP3 gene 
expression between the groups in the primary 
condition of the protocol. Therefore, we compared 
the groups at the post-test state using related factors 
as the covariates in pre-test state. There was a 
significant difference in the serum level of IL-35 and 
the amount of FoxP3 gene expression between both 
groups at the end of the protocol (p≤0.019) (Table 
3). 
Adjusting the effects of total duration of exercise 
activity, duration of ischemia history, and age of the 
participants, we performed further multivariate 
analysis of covariance on IL-35 and IL-33 serum 
levels and the amount of FoxP3 gene expression to 
compare the exercise group versus the control group 
after the termination of the exercise program. The 
results of analysis indicated that none of those 
covariates contributed significantly to such 
difference. This indicates that after the exclusion of 
the covariate effects, there was still a significant 
difference of IL-35 and FoxP3 expression between 
the groups (p≤0.042). The level of increase after 
adjustment for those variables remained significant 
(Table 4). 
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Table 1. Basic and clinical characteristics of the ischemic heart disease patients in submaximal exercise and control group 
Variants 
controls (n=23) 
(Mean±SD) 
exercise (n=21) 
(Mean±SD) 
p value 
Age (years) 64.78±12.21 58.5±7.9 0.035 
Duration of disease (months) 11.43±4.51 7.71±2.57 0.002 
Duration of exercise (hours)  9.61±27.31 27.29±22.84 0.026 
Pre-test IL-33 (pg/mL) 75.04±29 89.69±43.75 0.194 
Pre-test IL-35(pg/mL) 51.33±22.89 41.53±23.87 0.172 
Pre-test FoxP3 12.52±2.85 11.81±2.68 0.4 
 
 
 
 
Table 2. Comparing the levels of IL-35, IL-33, and FoxP3 expression in the ischemic heart disease patients in submaximal 
exercise and control groups in pre- and post-test condition 
Marker Group Before After Difference p value 
IL-35(pg/mL) 
Mean (SE) 
control 51.33 (4.77) 50.42 (4.45) -0.9 (2.4) 0.714 
exercise 41.53 (5.21) 57.79 (6.86) 16.3 (4.3) 0.001 
difference -9.79 7.36 - - 
p value 0.172 0.365 - - 
IL-33(pg/mL) 
Mean (SE) 
control 75.04 (6.05) 76.84 (7.84) 1.80 (7.33) 0.808 
exercise 89.69 (9.55) 89.95 (7.90) 0.26 (14.70) 0.986 
difference 14.65 (10.11) 13.10 (12.37) - - 
p value 0.194 0.269 - - 
FoxP3 (pg/mL) 
Mean (SE) 
control 12.52 (0.6) 11.87 (0.46) -0.65 (0.54) 0.243 
exercise 11.81 (0.58) 9.33 (0.87) -2.48 (0.90) 0.012 
difference 0.71 -2.5 - - 
p value 0.4 0.012 - - 
 
 
 
Table 3. Analysis of covariance (ANCOVA) for the serum levels of IL-35, IL-33, and the amount of FoxP3 gene expression in 
the ischemic heart disease patients in submaximal exercise and control groups using related covariates 
Model Unstandardized coefficients 
Standardized 
coefficients t p value 
  B Standard error β 
IL-35 
(pg/mL) 
constant 3.405 6.389  0.353 0.957 
IL-35 before 0.916 0.106 0.814 8.640 0.00 
group 16.335 4.995 0.11 3.279 0.002 
IL-33 
(pg/mL) 
constant 70.633 15.629  4.519 0.00 
IL-33before 0.083 0.174 0.075 0.477 0.636 
group 11.892 12.747 0.146 0.933 0.365 
FoxP3 
(pg/mL) 
constant 6.872 2.196  3.128 0.003 
FoxP3before 0.399 0.168 0.325 2.375 0.22 
group 2.252 0.019 -0.325 -2.450 0.019 
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Table 4. Multivariate analysis of covariance (ANCOVA) for the serum levels of IL-35 and IL-33 and the amount of FoxP3 
gene expression in the ischemic heart disease patients in submaximal exercise and control groups 
Model  
Unstandardized coefficients 
Standardized 
coefficients t p value 
B Standard error β 
IL-35(pg/ml) )constant( -20.527 19.201  -1.079 0.287 
IL-35before 0.905 0.107 0.803 8.444 0.00 
group 12.176 5.775 0.231 2.108 0.042 
length of ischemia -1.985 1.114 -0.294 -1.7 0.097 
duration of exercise 0.096 0.097 0.096 0.994 0.327 
age 0.699 0.393 0.0284 1.778 0.083 
IL-33(pg/ml) )constant( 71.360 48.925  1.495 -0.153 
IL-33 before 0.075 0.179 0.067 0.416 0.680 
group 20.302 15.124 0.250 1.342 0.187 
length of ischemia 2.790 2.973 0.280 0.938 0.354 
duration of exercise -0.066 0.263 -0.043 -0.253 0.802 
age -0.484 1.057 -0.128 -0.458 0.649 
FoxP3(pg/ml) )constant( 5.366 3.611  1.486 0.146 
FoxP3 before 0.301 0.174 0.245 1.730 0.092 
group -2.493 1.064 -0.371 -2.343 0.024 
length of ischemia -0.370 0.218 -0.450 -1.697 0.098 
duration of exercise -0.026 0.018 -0.202 -1.408 0.167 
age 0.111 0.077 0.355 1.438 0.159 
 
 
 
DISCUSSION 
 
This study was conducted to determine the effect of 
12 weeks of submaximal aerobic exercise on the serum 
levels of IL-35 and IL-33 in patients with symptom-
free ischemic heart disease. This exercise training 
program significantly improved the level of regulatory 
T cell-mediated markers of IL-35 and FoxP3 gene 
expression. 
Our study confirmed the anti-inflammatory role of 
submaximal aerobic exercise on serum level of IL-35 in 
patients with ischemic heart disease. These properties 
of IL-35, at least partly, are mediated through the 
proliferation of Tregs and inhibition of Th17 cells that 
play a significant role in recruitment of neutrophils, 
which in turn, intensify inflammatory processes.
29
 In 
the case of inflammation associated with ischemic heart 
disease, other studies have introduced IL-35 as a 
significant bio-marker in the incidence of coronary 
artery disease
30
 in a way that its decrease may be an 
indicator of ischemia.
31
 Such protective effect has also 
been shown in other inflammatory conditions.
32
 
 
The findings of this study is in agreement with 
some other investigations that  demonstrated the  anti-
inflammatory effects of Tregs, where moderate aerobic 
exercise increased the suppressive function of 
CD4+CD25+Foxp3+ cells on Th2 inflammatory 
responses including airway eosinophilia and allergen-
induced asthma.
33,34
 
According to our results, sub maximal aerobic does 
not make any significant changes in serum levels of IL-
33. However, one-session of an aerobic exercise made 
significant increases in the level of serum IL-33 in 
healthy young men and women.
35
 These contradictory 
findings to our study may be attributed to the different 
types of physical activities and populations employed. 
Considering blocking effects of Th2 cells on Th1 ones, 
we emphasize that more physical activity in severity 
and/or time may also change serum levels of IL-33 and 
confirm its protective roles in heart ischemia 
conditions. 
The amount of submaximal aerobic exercise applied 
in this research was sufficient to produce significant 
changes in regulatory T-cell markers of patients with 
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ischemic heart disease. However, the response to 
moderate level of aerobic physical activity may differ 
from that of intense and prolonged periods of 
endurance exercise. A recent report in mice, 
contradictory to human being, suggested that while 
intensive exercise increased Treg levels, moderate 
exercise had no effect on murine Tregs.
36
 The effects of 
exercise regarding its intensity have also been the focus 
of studies in which moderate aerobic exercise reduced 
the incidence of upper respiratory tract problems, while 
high intensity and prolonged course of aerobic exercise 
led to more upper respiratory tract infections in elite 
athletes.
36
 
It is likely that, other than exercise, some clinical 
features of our patients affect the production of Tregs. 
Considering a multivariate regression analysis, we 
confirmed that exercise was the only explanation for 
the observed results in our patients. 
Our study had some limitations. Firstly, there were 
no longitudinal follow-up measurements to evaluate the 
changes of selected markers during the time. This 
limitation allowed just a cross-sectional analysis with 
only a limited robustness. Secondly, functional assays 
which provide further information on the immune-
inhibitory effects of the molecules were not performed. 
It seems exercise may yield a better control of 
atherosclerotic inflammation in patients with ischemic 
heart disease through the induction of regulatory T 
cells. These findings may be used for both diagnostic 
approaches of stroke severity and therapeutic strategies. 
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